4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015882
Options or other derivatives
- Chief Scientific Officer acquired 82,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shanler Stuart · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-01 | Grant or award : show line 1 in the form Restricted stock units | +82,200 | 82,200 | D |
Loading xslF345X03/doc4.xml…